Nathan P Heinzerling1, Jennifer L Liedel2, Scott R Welak3, Katherine Fredrich4, Ben E Biesterveld1, Kirkwood A Pritchard4, David M Gourlay5. 1. Medical College of Wisconsin, Milwaukee, WI 53226, USA. 2. Division of Neonatology, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI 53226, USA; Division of Critical Care, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI 53226, USA. 3. Division of Neonatology, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI 53226, USA. 4. Division of Pediatric Surgery, Medical College of Wisconsin, Children's Research Institute, Milwaukee, WI 53226, USA. 5. Division of Pediatric Surgery, Medical College of Wisconsin, Children's Hospital of Wisconsin, Children's Research Institute, Milwaukee, WI 53226, USA. Electronic address: dgourlay@chw.org.
Abstract
BACKGROUND: Necrotizing enterocolitis (NEC) is the most common surgical emergency in neonates, with a mortality rate between 10 and 50%. The onset of necrotizing enterocolitis is highly variable and associated with numerous risk factors. Prior research has shown that enteral supplementation with intestinal alkaline phosphatase (IAP) decreases the severity of NEC. The aim of this study is to investigate whether IAP is protective to the preterm intestine in the presence of formula feeding and in the absence of NEC. METHODS: Preterm rat pups were fed formula with or without supplementation with IAP, and intestine was obtained on day of life 3 for analysis of IAP activity, mRNA expression of TNFα, IL-6 and iNOS and permeability and cytokine expression after LPS exposure. RESULTS: There was no difference in the absolute and intestine specific alkaline phosphatase activity in both groups. Rat pups fed IAP had decreased mRNA expression of the inflammatory cytokines TNFα, IL-6 and iNOS. Pups supplemented with IAP had decreased permeability and inflammatory cytokine expression after exposure to LPS ex vivo when compared to formula fed controls. CONCLUSIONS: Our results support that IAP is beneficial to preterm intestine and decreases intestinal injury and inflammation caused by LPS.
BACKGROUND:Necrotizing enterocolitis (NEC) is the most common surgical emergency in neonates, with a mortality rate between 10 and 50%. The onset of necrotizing enterocolitis is highly variable and associated with numerous risk factors. Prior research has shown that enteral supplementation with intestinal alkaline phosphatase (IAP) decreases the severity of NEC. The aim of this study is to investigate whether IAP is protective to the preterm intestine in the presence of formula feeding and in the absence of NEC. METHODS: Preterm rat pups were fed formula with or without supplementation with IAP, and intestine was obtained on day of life 3 for analysis of IAP activity, mRNA expression of TNFα, IL-6 and iNOS and permeability and cytokine expression after LPS exposure. RESULTS: There was no difference in the absolute and intestine specific alkaline phosphatase activity in both groups. Rat pups fed IAP had decreased mRNA expression of the inflammatory cytokines TNFα, IL-6 and iNOS. Pups supplemented with IAP had decreased permeability and inflammatory cytokine expression after exposure to LPS ex vivo when compared to formula fed controls. CONCLUSIONS: Our results support that IAP is beneficial to preterm intestine and decreases intestinal injury and inflammation caused by LPS.
Authors: Sundaram Ramasamy; Deanna D Nguyen; Michelle A Eston; Sayeda Nasrin Alam; Angela K Moss; Farzad Ebrahimi; Brishti Biswas; Golam Mostafa; Kathryn T Chen; Kanakaraju Kaliannan; Halim Yammine; Sonoko Narisawa; José Luis Millán; H Shaw Warren; Elizabeth L Hohmann; Emiko Mizoguchi; Hans-Christian Reinecker; Atul K Bhan; Scott B Snapper; Madhu S Malo; Richard A Hodin Journal: Inflamm Bowel Dis Date: 2011-02 Impact factor: 5.325
Authors: Rebecca Maria Rentea; Scott R Welak; Katherine Fredrich; Deborah Donohoe; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay; Jennifer L Liedel Journal: Eur J Pediatr Surg Date: 2012-11-19 Impact factor: 2.191
Authors: Rebecca M Rentea; Jennifer L Liedel; Scott R Welak; Laura D Cassidy; Alan N Mayer; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay Journal: J Pediatr Surg Date: 2012-06 Impact factor: 2.545
Authors: Jennifer L Liedel; Yuee Guo; Yueyue Yu; Sheng-Ru Shiou; Sangzi Chen; Elaine O Petrof; Shien Hu; Mark W Musch; Erika C Claud Journal: Pediatr Res Date: 2011-05 Impact factor: 3.756
Authors: Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay Journal: J Surg Res Date: 2012-06-01 Impact factor: 2.192
Authors: Kathryn T Chen; Madhu S Malo; Laura Kline Beasley-Topliffe; Klaas Poelstra; Jose Luis Millan; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin Journal: Dig Dis Sci Date: 2010-09-16 Impact factor: 3.199
Authors: Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Kirkwood Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay Journal: J Pediatr Surg Date: 2013-01 Impact factor: 2.545
Authors: Chhinder P Sodhi; Matthew D Neal; Richard Siggers; Shonan Sho; Congrong Ma; Maria F Branca; Thomas Prindle; Anthony M Russo; Amin Afrazi; Misty Good; Rachel Brower-Sinning; Brian Firek; Michael J Morowitz; John A Ozolek; George K Gittes; Timothy R Billiar; David J Hackam Journal: Gastroenterology Date: 2012-07-13 Impact factor: 22.682
Authors: Volker Mai; Christopher Michael Young; Maria Ukhanova; Xiaoyu Wang; Yijun Sun; George Casella; Douglas Theriaque; Nan Li; Renu Sharma; Mark Hudak; Josef Neu Journal: PLoS One Date: 2011-06-06 Impact factor: 3.240
Authors: Scott R Welak; Rebecca M Rentea; Ru-Jeng Teng; Nathan Heinzerling; Ben Biesterveld; Jennifer L Liedel; Kirkwood A Pritchard; Katherine M Fredrich; David M Gourlay Journal: PLoS One Date: 2014-12-17 Impact factor: 3.240
Authors: Marianna Parlato; Fabienne Charbit-Henrion; Jie Pan; Claudio Romano; Rémi Duclaux-Loras; Marie-Helene Le Du; Neil Warner; Paola Francalanci; Julie Bruneau; Marc Bras; Mohammed Zarhrate; Bernadette Bègue; Nicolas Guegan; Sabine Rakotobe; Nathalie Kapel; Paola De Angelis; Anne M Griffiths; Karoline Fiedler; Eileen Crowley; Frank Ruemmele; Aleixo M Muise; Nadine Cerf-Bensussan Journal: EMBO Mol Med Date: 2018-04 Impact factor: 12.137